<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="es">
	<id>https://cepem.wiki/index.php?action=history&amp;feed=atom&amp;title=15%25_Smaller_Than_Their_True_Size</id>
	<title>15% Smaller Than Their True Size - Historial de revisiones</title>
	<link rel="self" type="application/atom+xml" href="https://cepem.wiki/index.php?action=history&amp;feed=atom&amp;title=15%25_Smaller_Than_Their_True_Size"/>
	<link rel="alternate" type="text/html" href="https://cepem.wiki/index.php?title=15%25_Smaller_Than_Their_True_Size&amp;action=history"/>
	<updated>2026-11-19T21:26:05Z</updated>
	<subtitle>Historial de revisiones de esta página en la wiki</subtitle>
	<generator>MediaWiki 1.46.2</generator>
	<entry>
		<id>https://cepem.wiki/index.php?title=15%25_Smaller_Than_Their_True_Size&amp;diff=38635&amp;oldid=prev</id>
		<title>KeishaHollingswo: Página creada con «&lt;br&gt;Paul Weigel, Ph.D., obtained a B.A. Chemistry from Cornell University and his doctoral degree from The Johns Hopkins University School of Medicine in 1975. He joined the University of Texas Medical Branch at Galveston as an Assistant Professor in 1978 and became a Professor of Biochemistry and Cell Biology in 1987. Since 1994 he has been Professor and Chairman in the Department of Biochemistry &amp; Molecular Biology, College of Medicine, at the University of Oklahoma…»</title>
		<link rel="alternate" type="text/html" href="https://cepem.wiki/index.php?title=15%25_Smaller_Than_Their_True_Size&amp;diff=38635&amp;oldid=prev"/>
		<updated>2026-08-22T18:44:34Z</updated>

		<summary type="html">&lt;p&gt;Página creada con «&amp;lt;br&amp;gt;Paul Weigel, Ph.D., obtained a B.A. Chemistry from Cornell University and his doctoral degree from The Johns Hopkins University School of Medicine in 1975. He joined the University of Texas Medical Branch at Galveston as an Assistant Professor in 1978 and became a Professor of Biochemistry and Cell Biology in 1987. Since 1994 he has been Professor and Chairman in the Department of Biochemistry &amp;amp; Molecular Biology, College of Medicine, at the University of Oklahoma…»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Página nueva&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;br&amp;gt;Paul Weigel, Ph.D., obtained a B.A. Chemistry from Cornell University and his doctoral degree from The Johns Hopkins University School of Medicine in 1975. He joined the University of Texas Medical Branch at Galveston as an Assistant Professor in 1978 and became a Professor of Biochemistry and Cell Biology in 1987. Since 1994 he has been Professor and Chairman in the Department of Biochemistry &amp;amp; Molecular Biology, College of Medicine, at the University of Oklahoma Health Sciences Center in Oklahoma City. Dr. Weigel has made substantial research contributions in several fields, including the discoveries of multiple coated pit pathways for receptor-mediated endocytosis and of the enzyme responsible for hyaluronan biosynthesis. He has a long-standing interest in the biochemistry and  [https://shiningon.top/shantaexds3130/kathrin2014/wiki/Shothahara%3A-Reduces-Inflammation-in-the-Intestines Glyco Careswhite mulberry leaf] the biology of hyaluronan. His group was the first to identify and isolate the gene for hyaluronan synthase. Dr. Weigel’s laboratory also developed the use of structurally defined iodinated hyaluronan oligosaccharides of high specific radioactivity to detect and to study specific hyaluronan receptors and binding proteins.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;This approach enabled his laboratory to purify and then clone the rat and human liver endothelial cell receptors that remove circulating hyaluronan and other glycosaminoglycans from the blood by receptor mediated endocytosis. This membrane receptor has several designations, including HARE, the Hyaluronan Receptor for Endocytosis. The initial article (in 1998) on bacterial hyaluronan synthases in this series1 discussed what was known about the enzymes responsible for hyaluronan synthesis. After our discovery in 1993 of the first gene encoding an hyaluronan synthase from Group A Streptococcus, we and many others identified similar hyaluronan synthase genes (or cDNAs) in other bacteria and a wide range of eukaryotes2-6. 20 hyaluronan synthases comprise a family of proteins with common structural and mechanistic features. During the past five years, substantial progress has been made toward understanding the structure and function of the bacterial hyaluronan synthases and how they produce hyaluronan. We now know of four types of bacteria that produce hyaluronan capsules as part of their pathogenic arsenal for infecting various animal hosts.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bacteria that coat themselves with a thick layer of hyaluronan are able to &amp;quot; hide&amp;quot; from the immune systems of their host. These bacteria are Streptococcus equisimilis (a pathogen in animals and  [https://fly4fun.ru/blog/http-shadowthemescom-forums-users-wolfgang7256-edit-updatedtrue-users-wolfgang7256-.html Glyco Careswhite mulberry leaf] sometimes humans), Streptococcus pyogenes (a human pathogen), Streptococcus uberis (a bovine pathogen), and Pasteurella multocida (a fowl pathogen). Based on their similarities and differences, the known hyaluronan synthase proteins have been divided into two categories, designated Class I and Class II6. The streptococcal hyaluronan synthases are Class I family members, whereas the [https://www.rt.com/search?q=hyaluronan%20synthase hyaluronan synthase] from Pasteurella multocida (pmHAS) is the only Class II member7. 420 amino acids, although the topology has been experimentally determined only for the spHAS8. The Class I enzymes contain 6-8 transmembrane or membrane-associated domains distributed throughout the protein - from near the amino terminus to near the carboxyl terminus. Table 1 Structural and mechanistic differences between the Class I and Class II hyaluronan synthases.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In contrast, the Class II enzyme has a membrane attachment domain very near the carboxyl terminus that anchors the protein by an unknown mechanism; probably by interaction with another membrane-anchored component. The major mechanistic difference is that the two Classes of synthases extend hyaluronan at opposite ends of the polysaccharide. The Class II pmHAS adds new sugars to the nonreducing end, whereas the Class I enzymes extend at the reducing end. Unlike the Class I enzymes,  [https://shiningon.top/grettabuckman/4195glyco-care-blood-sugar-formulabitter-melon-extract/wiki/Fishing-for-Better-Blood-Sugar%3F Glyco Care blood sugar support] the Class II pmHAS has a two-domain modular structure with two transferase activities that alternatively bind and release hyaluronan chains to add new sugars to the nonreducing end by &amp;quot;classical&amp;quot; glycosyltransferase mechanisms. The rest of the Update will focus on new information about the Class I synthases. Fig. 1 Topological differences between Class I and Class II hyaluronan synthases. Top: The streptococcal Class I synthases (green line) contain four transmembrane domains and  [http://seoulbarunplant.com/bbs/board.php?bo_table=free&amp;amp;wr_id=540646 Glyco Care Supplementnatural glucose support] two membrane-associated domains8.&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>KeishaHollingswo</name></author>
	</entry>
</feed>